In light of (i) previous report highlighting glycosylation as a crucial androgen-regulated process that controls the viability of prostate cancer cells17 and (ii) our recent finding uncovering the reduction of a major subtype of fucosylation in male versus female melanomas16, we sought to assess if AR might transcriptionally control any fucosylation machinery genes. Here, AR is linked to prostate cancer.